These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 6726460)

  • 1. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
    Preusch PC; Suttie JW
    J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats.
    Fasco MJ; Preusch PC; Hildebrandt E; Suttie JW
    J Biol Chem; 1983 Apr; 258(7):4372-80. PubMed ID: 6833262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of vitamin K epoxide to hydroxyvitamin K by liver microsomes from warfarin-resistant rats.
    Nutr Rev; 1983 Aug; 41(8):253-4. PubMed ID: 6355923
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
    Yamanaka Y; Yamano M; Yasunaga K; Shike T; Uchida K
    Thromb Res; 1990 Jan; 57(2):205-14. PubMed ID: 2315885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
    Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
    Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal and warfarin-resistant rat hepatocyte metabolism of vitamin K 2,3-epoxide: evidence for multiple pathways of hydroxyvitamin K formation.
    Trivedi LS; Rhee M; Galivan JH; Fasco MJ
    Arch Biochem Biophys; 1988 Jul; 264(1):67-73. PubMed ID: 3395132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone.
    Mukharji I; Silverman RB
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2713-7. PubMed ID: 3857611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase.
    Hazelett SE; Preusch PC
    Biochem Pharmacol; 1988 Mar; 37(5):929-34. PubMed ID: 3345202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and purification of the vitamin K1 2,3 epoxide reductases system from rat liver.
    Begent LA; Hill AP; Steventon GB; Hutt AJ; Pallister CJ; Cowell DC
    J Pharm Pharmacol; 2001 Apr; 53(4):481-6. PubMed ID: 11341364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal variation in the effects of warfarin on the vitamin K cycle.
    Soulban G; Labrecque G; Bélanger PM
    Chronobiol Int; 1990; 7(5-6):403-11. PubMed ID: 2097073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K1 hydroquinone formation catalyzed by a microsomal reductase system.
    Fasco MJ; Principe LM
    Biochem Biophys Res Commun; 1980 Dec; 97(4):1487-92. PubMed ID: 7213374
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
    Creedon KA; Suttie JW
    Thromb Res; 1986 Oct; 44(2):147-53. PubMed ID: 3787564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
    Fasco MJ; Hildebrandt EF; Suttie JW
    J Biol Chem; 1982 Oct; 257(19):11210-2. PubMed ID: 6811577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K activity and metabolism of vitamin K-1 epoxide-1,4-diol.
    Bell RG
    J Nutr; 1982 Feb; 112(2):287-92. PubMed ID: 7057266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.
    Lee JJ; Principe LM; Fasco MJ
    Biochemistry; 1985 Dec; 24(25):7063-70. PubMed ID: 4084561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF; Suttie JW
    Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.
    Wallin R; Martin LF
    J Clin Invest; 1985 Nov; 76(5):1879-84. PubMed ID: 3932474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats.
    Hallak HO; Wedlund PJ
    Drug Metab Dispos; 1991; 19(1):278-9. PubMed ID: 1673414
    [No Abstract]   [Full Text] [Related]  

  • 19. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
    Fasco MJ; Principe LM; Walsh WA; Friedman PA
    Biochemistry; 1983 Nov; 22(24):5655-60. PubMed ID: 6652076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fibroblast cell culture model to study vitamin K metabolism and the inhibition of vitamin K epoxide reductase by known and suspected antagonists.
    Ross PJ; Shearer MJ; Diplock AT; Schey SA
    Br J Haematol; 1991 Feb; 77(2):195-200. PubMed ID: 2004021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.